Search Results 461-470 of 17359 for Teratogenic

  1. High-Dimensional Phenotyping: Charles J. Bruce, Rickey E. Carter, Antonio J. Forte, Clifton R. Haider, Christopher J. McLeod

    Mayo Clinic's High-Dimensional Phenotyping Lab is a translational research & innovation lab that seeks to understand physiology at scale & deploy rigorous, ...

  2. A Study of DNA/RNA Sequencing Results on the Clinical Management of Patients with Advanced Malignancies

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Preoperative Radioactive Seed Localization of Nonpalpable Soft Tissue Masses - Mayo Clinic

    The purpose of this study is to see if there is a subjective improvement in operative time, incision length, volume of tissue removed and margin status when ...

  4. Biological Therapy For Cancer Clinical Trials - Mayo Clinic Research

    This study will test a study drug called cemiplimab to see if it can help treat early-stage cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

  5. Retifanlimab With Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma - Mayo Clinic

    ... teratogenic effects on the developing fetus and newborn are unknown: * Pregnant persons * Nursing persons * Persons of childbearing potential who are ...

  6. Pentosan polysulfate sodium (oral route) - Side effects & dosage - Mayo Clinic

    Pentosan polysulfate sodium is used to relieve the symptoms (eg, pain, discomfort) of interstitial cystitis (inflammation of the bladder). This medicine is ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Neurosurgery - Clinical trials

    Learn how neurosurgeons help people with complex conditions by using advanced techniques, such as awake brain surgery and minimally invasive spine surgery.

  9. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in ...

  10. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...